Lidorestat (IDD-676) is a potent, selective and orally active aldose reductase inhibitor with an IC50 of 5 nM. Lidorestat can be used for chronic diabetes complications. Lidorestat also improves nerve conduction and reduces cataract formation[1][2][3].
Molecular Weight:
376.35
Purity:
99.5
CAS Number:
[245116-90-9]
Formula:
C18H11F3N2O2S
Target:
Aldose Reductase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
